MDT
97.17
+2.33%↑
VEEV
295.69
+0.08%↑
A
141.95
+2.63%↑
HQY
90.19
-0.24%↓
PHR.US
23.94
+5.88%↑
MDT
97.17
+2.33%↑
VEEV
295.69
+0.08%↑
A
141.95
+2.63%↑
HQY
90.19
-0.24%↓
PHR.US
23.94
+5.88%↑
MDT
97.17
+2.33%↑
VEEV
295.69
+0.08%↑
A
141.95
+2.63%↑
HQY
90.19
-0.24%↓
PHR.US
23.94
+5.88%↑
MDT
97.17
+2.33%↑
VEEV
295.69
+0.08%↑
A
141.95
+2.63%↑
HQY
90.19
-0.24%↓
PHR.US
23.94
+5.88%↑
MDT
97.17
+2.33%↑
VEEV
295.69
+0.08%↑
A
141.95
+2.63%↑
HQY
90.19
-0.24%↓
PHR.US
23.94
+5.88%↑
24h
Actuel
Min
2.68
Max
2.84
Recommandations | Achat |
---|---|
Prévisions sur 12 Mois | +417.86% upside |
Prochains Résultats | 12 nov. 2025 |
---|
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
1 oct. 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
Lire
10 mars 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Lire
10 mars 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Lire
10 mars 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Lire
10 mars 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Lire
10 mars 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Lire
10 mars 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Lire
10 mars 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Lire
Variation de prix
By TipRanks
Prévisions sur 12 Mois
Moyen 14.5 USD 417.86%
Haut 17 USD
Bas 12 USD
Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.
By TipRanks
Achat
2 ratings
2
Achat
0
Maintien
0
Vente
Basé sur 2 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.
$